Franklin Street Advisors’s ProQR Therapeutics PRQR Stock Holding History

Franklin Street Advisors’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$279K	Hold	150,000	–	–	0.02%	155
2026 Q1	$243K	Hold	150,000	–	–	0.01%	151
2025 Q4	$303K	Hold	150,000	–	–	0.02%	141
2025 Q3	$320K	Hold	150,000	–	–	0.02%	135
2025 Q2	$306K	Hold	150,000	–	–	0.02%	139
2025 Q1	$200K	Hold	150,000	–	–	0.01%	157
2024 Q4	$398K	Hold	150,000	–	–	0.03%	123
2024 Q3	$273K	Hold	150,000	–	–	0.02%	148
2024 Q2	$249K	Hold	150,000	–	–	0.02%	148
2024 Q1	$343K	Hold	150,000	–	–	0.03%	124
2023 Q4	$297K	Hold	150,000	–	–	0.02%	126
2023 Q3	$195K	Hold	150,000	–	–	0.02%	143
2023 Q2	$243K	Hold	150,000	–	–	0.02%	130
2023 Q1	$320K	Hold	150,000	–	–	0.03%	109
2022 Q4	$555K	Hold	150,000	–	–	0.05%	94
2022 Q3	$112K	Hold	150,000	–	–	0.01%	136
2022 Q2	$117K	Buy	150,000 +50,000	+50%	+$37.3K	0.01%	143
2022 Q1	$91K	Sell	100,000 -10,000	-9%	-$33.5K	0.01%	154
2021 Q4	$881K	Buy	110,000 +10,000	+10%	+$76.1K	0.07%	89
2021 Q3	$837K	Hold	100,000	–	–	0.07%	88
2021 Q2	$674K	Hold	100,000	–	–	0.06%	95
2021 Q1	$661K	Buy	100,000 +40,000	+67%	+$204K	0.06%	97
2020 Q4	$252K	Hold	60,000	–	–	0.02%	129
2020 Q3	$287K	Hold	60,000	–	–	0.03%	117
2020 Q2	$365K	Hold	60,000	–	–	0.04%	108
2020 Q1	$329K	Hold	60,000	–	–	0.05%	102
2019 Q4	$595K	Hold	60,000	–	–	0.07%	97
2019 Q3	$346K	Hold	60,000	–	–	0.04%	117
2019 Q2	$546K	Hold	60,000	–	–	0.07%	101
2019 Q1	$832K	Hold	60,000	–	–	0.12%	83
2018 Q4	$947K	Hold	60,000	–	–	0.15%	81
2018 Q3	$1.16M	Sell	60,000 -30,000	-33%	-$319K	0.16%	80
2018 Q2	$657K	Buy	90,000 +30,000	+50%	+$151K	0.1%	87
2018 Q1	$185K	Buy	+60,000	New	+$193K	0.03%	153

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Franklin Street Advisors's PRQR Position: Q2 2026 in Review

Franklin Street Advisors held its ProQR Therapeutics (PRQR) position steady in Q2 2026 at 150,000 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #155.

Franklin Street Advisors first reported a position in PRQR in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.16M in Q3 2018. 70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

Franklin Street Advisors held 150,000 shares of ProQR Therapeutics worth $279K as of Q2 2026.
Franklin Street Advisors left its ProQR Therapeutics share count unchanged in Q2 2026.
ProQR Therapeutics made up 0.02% of Franklin Street Advisors's portfolio in Q2 2026, its #155 holding.
Franklin Street Advisors first reported a position in ProQR Therapeutics in Q1 2018 and has held it in 34 quarters since.
Franklin Street Advisors's ProQR Therapeutics position peaked at $1.16M in Q3 2018.
70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.